Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [978]
News [2837]
Articles [135]
Editorials [3]
Conferences [92]
elearning [27]

Can SBRT be of use for early, operable non-small cell lung cancer?

Dr Joe Chang – University of Texas MD Anderson Cancer Center, Houston, USA
Can SBRT be of use for early, operable non-small cell lung cancer? ( Dr Joe Chang – University of Texas MD Anderson Cancer Center, Houston, USA )
23 Oct 2015

Investigating genetic vulnerabilities to radiation therapy

Dr Mohamed Abazeed – Cleveland Clinic, Cleveland, USA
Investigating genetic vulnerabilities to radiation therapy ( Dr Mohamed Abazeed – Cleveland Clinic, Cleveland, USA )
23 Oct 2015

Is lung cancer screening ready for implementation in Europe?

Dr Giulia Veronesi - Humanitas Research Hospital, Milan, Italy
Is lung cancer screening ready for implementation in Europe? ( Dr Giulia Veronesi - Humanitas Research Hospital, Milan, Italy )
6 Oct 2015

First ‘targeted’ treatment for small cell lung cancer shows promise

Dr Catherine Pietanza - Memorial Sloan Cancer Center, New York, USA
First ‘targeted’ treatment for small cell lung cancer shows promise ( Dr Catherine Pietanza - Memorial Sloan Cancer Center, New York, USA )
2 Oct 2015

Examining NSCLC responses to durvalumab monotherapy

Brandon Higgs - MedImmune, Gaithersburg, USA
Examining NSCLC responses to durvalumab monotherapy ( Brandon Higgs - MedImmune, Gaithersburg, USA )
1 Oct 2015

Expanding access to crizotinib using a biomarker-driven approach

Prof Gilles Vassal - University Paris-Sud, Orsay, France
Expanding access to crizotinib using a biomarker-driven approach ( Prof Gilles Vassal - University Paris-Sud, Orsay, France )
1 Oct 2015

ECC 2015 scientific highlights

Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden
ECC 2015 scientific highlights ( Prof Peter Naredi - University of Gothenburg, Gothenburg, Sweden )
30 Sep 2015

Atezolizumab for locally advanced or metastatic PD-L1-selected NSCLC

Dr Benjamin Besse - Institut Gustave Roussy, Villejuif, France
Atezolizumab for locally advanced or metastatic PD-L1-selected NSCLC ( Dr Benjamin Besse - Institut Gustave Roussy, Villejuif, France )
30 Sep 2015

Rova-T: First ‘targeted’ treatment for small cell lung cancer shows promise

Dr Catherine Pietanza - Memorial Sloan Kettering Cancer Center, New York, USA
Rova-T: First ‘targeted’ treatment for small cell lung cancer shows promise ( Dr Catherine Pietanza - Memorial Sloan Kettering Cancer Center, New York, USA )
28 Sep 2015

Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC

Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium
Atezolizumab monotherapy vs docetaxel in 2nd and 3rd line NSCLC ( Prof Johan Vansteenkiste - University Hospital Leuven, Leuven, Belgium )
28 Sep 2015

Latest in lung cancer from ECC 2015

Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany
Latest in lung cancer from ECC 2015 ( Prof Martin Reck - Lung Clinic Grosshansdorf, Grosshansdorf, Germany )
28 Sep 2015

Tackling global radiotherapy shortfall could save millions of lives and boost the economy of poorer countries

Prof Rifat Atun - Harvard University, Boston, USA
Tackling global radiotherapy shortfall could save millions of lives and boost the economy of poorer countries ( Prof Rifat Atun - Harvard University, Boston, USA )
26 Sep 2015

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation